In the intricate symphony of human physiology, few instruments play a more pivotal role than the heart. A marvel of ...

Geoff Martha affirmed commitment to profitable growth, reiterating FY25 guidance of mid-single-digit revenue and high-single-digit EPS growth. Larry Biegelsen, Wells Fargo: Asked about cardiac ...

The medical device maker reported adjusted EPS of $1.39, beating the consensus ... with mid-single digit increases in Cardiac Rhythm & Heart Failure and Structural Heart & Aortic and a low-single ...

Currency-adjusted EPS for the reported quarter was $1.38 ... Cardiovascular revenues increased 5% organically to $3.04 billion. Within this, Cardiac Rhythm & Heart Failure sales totaled $1. ...